|
TIMM17A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.889400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.211400E-01 |
| Normal-vs-Stage2 |
7.316000E-01 |
| Normal-vs-Stage3 |
1.441840E-01 |
| Normal-vs-Stage4 |
8.630400E-01 |
| Stage1-vs-Stage2 |
7.801600E-01 |
| Stage1-vs-Stage3 |
9.213800E-02 |
| Stage1-vs-Stage4 |
8.899400E-01 |
| Stage2-vs-Stage3 |
3.689800E-01 |
| Stage2-vs-Stage4 |
9.523200E-01 |
| Stage3-vs-Stage4 |
4.596200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.088000E-01 |
| Normal-vs-AfricanAmerican |
4.656600E-01 |
| Normal-vs-Asian |
7.473600E-01 |
| Caucasian-vs-AfricanAmerican |
5.751600E-01 |
| Caucasian-vs-Asian |
7.834200E-01 |
| AfricanAmerican-vs-Asian |
8.623200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.048800E-01 |
| Normal-vs-Female |
5.642200E-02 |
| Male-vs-Female |
2.119600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.763600E-01 |
| Normal-vs-Extreme_Weight |
7.641200E-01 |
| Normal-vs-Obese |
9.173600E-01 |
| Normal-vs-Extreme_Obese |
5.037600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.627000E-01 |
| Normal_Weight-vs-Obese |
7.815000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.983600E-01 |
| Extreme_Weight-vs-Obese |
8.834000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.541800E-01 |
| Obese-vs-Extreme_Obese |
5.284400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.383400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.940600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.736200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.599630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.617200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.483200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.342300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.271800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.352600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.336830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.452000E-01 |
| Normal-VS-Type2 PRCC |
4.018100E-02 |
| Normal-VS-KIRP CIMP |
9.508600E-01 |
| Normal-VS-Unclassified PRCC |
8.170400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.636500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.221600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.775200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.548000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.257980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.512800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.956400E-01 |
| Normal-vs-N1 |
2.369600E-01 |
| Normal-vs-N2 |
9.139000E-01 |
| N0-vs-N1 |
2.160200E-01 |
| N0-vs-N2 |
8.919000E-01 |
| N1-vs-N2 |
7.047200E-01 |
|
|
